Navigation Links
Bluestar Silicones to Present Antimicrobial Silicones at Medical Silicones Conference in Boston
Date:9/27/2011

EAST BRUNSWICK, N.J., Sept. 27, 2011 /PRNewswire/ -- Bluestar Silicones Senior Scientist Dr. Olga Hoy, Ph.D., will present "Silicone Material to Control Bacterial Growth" at the upcoming Medical Silicones Conference in Boston, October 4-5.

According to Dr. Hoy, the rising number of hospital acquired infections, increasing cost of medical care and the aging population are factors that contribute to growing demand for medical devices and consumer goods that incorporate antimicrobial properties.

In her presentation, Dr. Hoy will explore the various factors medical device and consumer goods companies should consider in their quest for antimicrobial silicone materials.  From additive selection, to additive interaction with the silicone, to manufacturing process, to regulatory considerations, Dr. Hoy will demonstrate how a customized approach enables manufacturers to optimize the use of antimicrobials.

As a gold sponsor of the Medical Silicones Conference, Bluestar Silicones will host a tabletop display at the event highlighting its Silbione® brand adhesive silicone materials designed specifically for healthcare and medical applications.  For more information about Bluestar Silicones, call 1-866-474-6342.

About Dr. HoyDr. Olga Hoy is a senior scientist at Bluestar Silicones where she has been focused on antimicrobial silicones for the last 3 years.  She holds a Ph.D. in material sciences and engineering from Clemson University, Clemson, S.C., and an M.S. degree in pharmaceutical technology from Lviv Polytechnic National University, Lviv, Ukraine.

About Bluestar SiliconesWith worldwide operations headquartered in Lyon, France, Bluestar Silicones is a $650 million worldwide silicones raw material manufacturer.  Bluestar is one of the world's leading fully integrated global silicones manufacturers with more than 50 years of silicone expertise. Bluestar has manufacturing operations throughout the world and offers a comprehensive range of silicone technologies in support of diverse specialty markets including paper release, textile coatings, healthcare, moldmaking, automotive, aerospace and personal care.  For more information, call (866) 474-6342 or visit www.bluestarsilicones.com.Press Contact: Karen O'Keefe, (732) 227-2089karen.okeefe@bluestarsilicones.com
'/>"/>

SOURCE Bluestar Silicones
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bluestar Silicones Introduces its New Silbione(R) Products for Healthcare at MEDICA 2010 in Dusseldorf
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
10. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):